Could a chemo cocktail before standard care keep esophageal cancer away?
NCT ID NCT03110926
First seen Nov 01, 2025 · Last updated May 15, 2026 · Updated 32 times
Summary
This study tests whether giving a specific chemotherapy combination (mFOLFOX6) before the usual chemoradiation and surgery can help prevent esophageal cancer from coming back. About 40 adults with locally advanced esophageal cancer that can be surgically removed are participating. The main goal is to see if this approach improves the chance of being cancer-free two years after treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ESOPHAGEAL CARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University of Rochester
Rochester, New York, 14642, United States
Conditions
Explore the condition pages connected to this study.